The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Vesicles of variable sizes produced by a rapid extrusion procedure
Mayer, L. D., Hope, M. J., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90302-0 · Cited by 1,691
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Self-citationAllen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
Self-citationGabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
Applied Biopharmaceutics and Pharmacokinetics.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-6-826_2 · Cited by 1,206
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizon, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,131
Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669
Muggia, F. M., Hainsworth, J. D., Jeffers, S., Miller, P., Groshen, S., Tan, M., Roman, L., Uziely, B., Muderspach, L., Garcia, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.987 · Cited by 647
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Serum-induced leakage of liposome contents
Allen, T. M., & Cleland, L. G. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90118-2 · Cited by 468
Self-citationAllen, T. M., Hansen, C., & Rutledge, J. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90078-3 · Cited by 466
Self-citationGabizón, A. (1992) · PubMed · Cited by 421
Applied Biopharmaceutics and Pharmacokinetics
Bollish, S. J. (1981) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/38.9.1400 · Cited by 380
Mayer, L. D., Tai, L. C. L., Ko, D. S. C., Masin, D., Ginsberg, R. S., Cullis, P. R., & Bally, M. B. (1989) · PubMed · Cited by 353
Pharmacokinetics of long-circulating liposomes
Allen, T. M., Hansen, C. B., & de Menezes, D. E. L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00029-7 · Cited by 305
Self-citationRanson, M. R., Carmichael, J., O'Byrne, K., Stewart, S., Smith, D., & Howell, A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3185 · Cited by 293
Waterhouse, D. N., Tardi, P. G., Mayer, L. D., & Bally, M. B. (2001) · Drug Safety · doi:10.2165/00002018-200124120-00004 · Cited by 242
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes
Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., Martin, F. J., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90194-q · Cited by 241
Berry, G., Billingham, M., Alderman, E., Richardson, P., Torti, F., Lum, B., Patek, A., & Martin, F. J. (1998) · Annals of Oncology · doi:10.1023/a:1008216430806 · Cited by 241
Gabizon, A. A., Barenholz, Y., & Bialer, M. (1993) · Pharmaceutical Research · doi:10.1023/a:1018907715905 · Cited by 237
Gabizon, A., Goren, D., Horowitz, A. T., Tzemach, D., Lossos, A., & Siegal, T. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00476-0 · Cited by 221
Gabizon, A., Shiota, R., & Papahadjopoulos, D. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.19.1484 · Cited by 219
Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin
Lotem, M., Hubert, A., Lyass, O., Goldenhersh, M. A., Ingber, A., Peretz, T., & Gabizon, A. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.12.1475 · Cited by 219
Bolotin, E. M., Cohen, R., Bar, L. K., Emanuel, N., Ninio, S., Barenholz, Y., & Lasic, D. D. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037057 · Cited by 207
Charrois, G. J. R., & Allen, T. M. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00661-2 · Cited by 170
Self-citationStealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen, T. M., Mehra, T., Hansen, C., & Chin, Y. C. (1992) · PubMed · Cited by 159
Self-citationPharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
Working, P. K., & Dayan, A. D. (1996) · PubMed · Cited by 156
Bandak, S., Goren, D., Horowitz, A. T., Tzemach, D., & Gabizon, A. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199911000-00007 · Cited by 137
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
Cowens, J. W., Creaven, P. J., Greco, W. R., Brenner, D. E., Tung, Y., Ostro, M. J., Pilkiewicz, F. G., Ginsberg, R. S., & Petrelli, N. J. (1993) · PubMed · Cited by 136
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
Multiple Injections of Pegylated Liposomal Doxorubicin: Pharmacokinetics and Therapeutic Activity
Charrois, G. J. R., & Allen, T. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053413 · Cited by 136
Self-citationMayer, L. D., Bally, M. B., Loughrey, H. C., Masin, D., & Cullis, P. R. (1990) · PubMed · Cited by 111
DERKSEN, J. T. P., Morselt, H. W. M., & Scherphof, G. L. (1987) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(87)90047-4 · Cited by 87
Influence of Drug Release Characteristics on the Therapeutic Activity of Liposomal Mitoxantrone
Lim, H. J., Masin, D., Madden, T. D., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36596-6 · Cited by 83
Gabizon, A., Hliberty, J., Straubinger, R. M., Price, D. C., & Papahadjopoulos, D. (1988) · Journal of Liposome Research · doi:10.3109/08982108809035986 · Cited by 82
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
Moase, E. H., Qi, W., Ishida, T., Gabos, Z., Longenecker, B. M., Zimmermann, G., Ding, L., Krantz, M. J., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00334-5 · Cited by 80
Self-citationHarasym, T. O., Cullis, P. R., & Bally, M. B. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050662 · Cited by 59
Cutaneous Reactions to Chemotherapy Drugs
Remlinger, K. A. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.1.77 · Cited by 46
Cited by
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Self-citationTumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 877
Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.066 · Cited by 849
Cancer nanotechnology: application of nanotechnology in cancer therapy
Misra, R., Acharya, S., & Sahoo, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.006 · Cited by 702
Metadata
- Authors
- Charrois, G. J. R., & Allen, T. M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 1663
- Issue
- 1-2
- Pages
- 167-177
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2063338965
- Cited by
- 300
- References
- 42
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.